Acute Leukemia Working Party (ALWP)
Study type:
Study number:
8421103
Type of treatment:
Allogeneic
Diseases:
Acute Myeloid Leukaemia (AML)
Acute Lymphatic Leukaemia (ALL)
Short title:
Prevalence and outcome of CNS relapse after alloHSCT in patients suffering from AML and ALL
Primary objective:
Key inclusion criteria:
Country:
Principal investigator:
Sabine BLUM , Yves Chalandon
EBMT Study coordinator:
Audrey MAILHOL
Study coordinator email:
audreymailhol@upmc.fr